ANGELICO, MARIO
ANGELICO, MARIO
Dipartimento di Medicina dei sistemi
13C-methacetin breath test for monitoring hepatic function in cirrhotic patients before and after liver transplantation
2003-10-15 Petrolati, A; Festi, D; De Berardinis, G; Colaiocco Ferrante, L; DI PAOLO, D; Tisone, G; Angelico, M
13C-methacetin breath test for monitoring hepatic function in cirrhotic patients before and after liver transplantation.
2003-01-01 Petrolati, A; Festi, D; De Berardinis, G; Colaiocco Ferrante, L; Di Paolo, D; Tisone, G; Angelico, M
596
2008-01-01 Lenci, I; Tariciotti, L; Baiocchi, L; Manzia, Tm; Toti, L; Craboledda, P; Callea, F; Angelico, M; Tisone, G
[The medical therapy of cholelithiasis. Critical reflections]
1998-01-01 Angelico, M
A Bayesian methodology to improve prediction of early graft loss after liver transplantation derived from the Liver Match study
2014-01-09 Angelico, M; Nardi, A; Romagnoli, R; Marianelli, T; Corradini, S; Tandoi, F; Gavrila, C; Salizzoni, M; Pinna, A; Cillo, U; Gridelli, B; De Carlis, L; Colledan, M; Gerunda, G; Costa, A; Strazzabosco, M
A Hyper-Glycosylation of HBV Surface Antigen Correlates with HBsAg-Negativity at Immunosuppression-Driven HBV Reactivation in Vivo and Hinders HBsAg Recognition in Vitro
2020-02-23 Salpini, R; Piermatteo, L; Battisti, A; Colagrossi, L; Aragri, M; Yu La Rosa, K; Bertoli, A; Saccomandi, P; Lichtner, M; Marignani, M; Maylin, S; Delaugerre, C; Morisco, F; Coppola, N; Marrone, A; Iapadre, N; Cerva, C; Aquaro, S; Angelico, M; Sarmati, L; Andreoni, M; Verheyen, J; Ceccherini-Silberstein, F; Levrero, M; Perno, Cf; Belloni, L; Svicher, V
A Multistep, Consensus-Based Approach to Organ Allocation in Liver Transplantation: Toward a "blended Principle Model"
2015-01-01 Cillo, U; Burra, P; Mazzaferro, V; Belli, L; Pinna, A; Spada, M; Nanni Costa, A; Toniutto, P; Avolio, A; Cescon, M; Romagnoli, R; Santaniello, W; Rossi, M; Corno, V; Caraceni, P; Coco, B; Fraquelli, M; Rendina, M; Angelico, M; Fagiuoli, S; Bruno, R; Costa, A; Ridolfi, L; Romagnoli, R; Pretagostini, R; Amoroso, A; Biancofiore, G; De Gasperi, A; Rocca, G; Feltracco, P; Colli, A; Sacchini, D; Pegoraro, R; Gardini, I; Pipit, P; Maffeo, C; Rossellini, S
A pilot study on the safety and effectiveness of immunosuppression without prednisone after liver transplantation
1999-01-01 Tisone, G; Angelico, M; Palmieri, G; Pisani, F; Anselmo, A; Baiocchi, L; Negrini, S; Orlando, G; Vennarecci, G; Casciani, Cu
A randomized controlled trial of amantadine plus interferon-alpha 2a vs. interferon-alpha 2a alone in naive patients with chronic hepatitis C randomized according to the early virological response to interferon-alpha 2a monotherapy
2004-01-01 Angelico, M; Cepparulo, M; Angelico, F; Francioso, S; Barlattani, A; Di Candilo, F; Della Vecchiai, R; Demelia, L; De Sanctis, G; Gentile, S; Grieco, A; Parruti, G; Sabusco, G; Tarquini, L; Tosti, A; Zaru, S
A randomized controlled trial of pegylated interferon-alpha2a plus adefovir dipivoxil for hepatitis B e antigen-negative chronic hepatitis B
2009-01-01 Piccolo, P; Lenci, I; Demelia, L; Bandiera, F; Piras, M; Antonucci, G; Nosotti, L; Mari, T; De Santis, A; Ponti, M; Sorbello, O; Iacomi, F; Angelico, M
A randomized controlled trial of sequential pegylated interferon-α and telbivudine or vice versa for 48 weeks in hepatitis B e antigen-negative chronic hepatitis B
2013-08-01 Piccolo, P; Lenci, I; DI PAOLO, D; Demelia, L; Sorbello, O; Nosotti, L; Angelico, M
A randomized study on Peg-interferon alfa-2a with or without ribavirin in liver transplant recipients with recurrent hepatitis C
2007-01-01 Angelico, M; Petrolati, A; Lionetti, R; Lenci, I; Burra, P; Donato, M; Merli, M; Strazzabosco, M; Tisone, G
A randomized study on Peg-interferon alfa-2a with or without ribavirin in liver transplant recipients with recurrent hepatitis C.
2007-01-01 Angelico, M; Petrolati, A; Lionetti, R; Lenci, I; Burra, P; Donato, M; Merli, M; Strazzabosco, M; Tisone, G
A simple rule to personalize standard dual therapy across all genotypes in naive chronic hepatitis C patients: The TT4 randomized trial
2014-02-01 Francioso, S; Almerighi, C; Forte, P; Bandiera, F; Nosotti, L; Lionetti, R; Taliani, G; Piras, M; Ponti, M; Parruti, G; Di Candilo, F; Gentile, S; Piccolo, P; Salso, A; Riccobelli, F; Renzi, S; Longo, M; Montalbano, M; Zaru, S; Biliotti, E; Di Masi, F; Santopaolo, F; Angelico, M
A snapshot of virological presentation and outcome of immunosuppression-driven HBV reactivation from real clinical practice: Evidence of a relevant risk of death and evolution from silent to chronic infection
2019-07-26 Salpini, R; Battisti, A; Colagrossi, L; Di Carlo, D; Fabeni, L; Piermatteo, L; Cerva, C; Lichtner, M; Mastroianni, C; Marignani, M; Maylin, S; Delaugerre, C; Morisco, F; Coppola, N; Marrone, A; Angelico, M; Sarmati, L; Andreoni, M; Perno, C-; Ceccherini-Silberstein, F; Svicher, V
A survey on mortality from non-variceal upper gastrointestinal bleeding: Is the emergency referral system adequate?
2013-11-01 Cesaro, P; Kohn, A; Petruziello, L; Angelico, M; Franceschi, F; Gigliozzi, A; Lamazza, A; Tammaro, L; Boschetto, S; Brighi, S; Antoniozzi, A; Baiocchi, L
Ab initio calcineurin inhibitor-based monotherapy immunosuppression after liver transplantation reduces the risk for Pneumocystis jirovecii pneumonia.
2010-01-01 Orlando, G; Tariciotti, L; Manzia, Tm; Gravante, G; Sorge, R; Manuelli, M; Pisani, F; Di Cocco, P; Scelzo, C; Burke, G; Soker, S; Baiocchi, L; Lerut, J; Angelico, M; Tisone, G
Abnormalities in erythrocyte membrane phospholipids in patients with liver cirrhosis
1982-10-01 Alvaro, D; Angelico, M; Attili, A; De Santis, A; Piéche, U; Capocaccia, L
Activation of the IGF1 system characterizes cholangiocyte survival during progression of primary biliary cirrhosis
2007-01-01 Nori, P; Alvaro, D; Floreani, A; Mancino, M; Franchitto, A; Guido, M; Carpino, G; De Santis, A; Angelico, M; Attili, A; Gaudio, E
Acute Cholangitis with Atypical Clinical Presentation and Imaging
2019-01-01 Masetti, C; Brega, A; Angelico, M
Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
---|---|---|---|---|
15-ott-2003 | 13C-methacetin breath test for monitoring hepatic function in cirrhotic patients before and after liver transplantation | Petrolati, A; Festi, D; De Berardinis, G; Colaiocco Ferrante, L; DI PAOLO, D; Tisone, G; Angelico, M | Articolo su rivista | |
1-gen-2003 | 13C-methacetin breath test for monitoring hepatic function in cirrhotic patients before and after liver transplantation. | Petrolati, A; Festi, D; De Berardinis, G; Colaiocco Ferrante, L; Di Paolo, D; Tisone, G; Angelico, M | Articolo su rivista | |
1-gen-2008 | 596 | Lenci, I; Tariciotti, L; Baiocchi, L; Manzia, Tm; Toti, L; Craboledda, P; Callea, F; Angelico, M; Tisone, G | Articolo su rivista | |
1-gen-1998 | [The medical therapy of cholelithiasis. Critical reflections] | Angelico, M | Articolo su rivista | |
9-gen-2014 | A Bayesian methodology to improve prediction of early graft loss after liver transplantation derived from the Liver Match study | Angelico, M; Nardi, A; Romagnoli, R; Marianelli, T; Corradini, S; Tandoi, F; Gavrila, C; Salizzoni, M; Pinna, A; Cillo, U; Gridelli, B; De Carlis, L; Colledan, M; Gerunda, G; Costa, A; Strazzabosco, M | Articolo su rivista | |
23-feb-2020 | A Hyper-Glycosylation of HBV Surface Antigen Correlates with HBsAg-Negativity at Immunosuppression-Driven HBV Reactivation in Vivo and Hinders HBsAg Recognition in Vitro | Salpini, R; Piermatteo, L; Battisti, A; Colagrossi, L; Aragri, M; Yu La Rosa, K; Bertoli, A; Saccomandi, P; Lichtner, M; Marignani, M; Maylin, S; Delaugerre, C; Morisco, F; Coppola, N; Marrone, A; Iapadre, N; Cerva, C; Aquaro, S; Angelico, M; Sarmati, L; Andreoni, M; Verheyen, J; Ceccherini-Silberstein, F; Levrero, M; Perno, Cf; Belloni, L; Svicher, V | Articolo su rivista | |
1-gen-2015 | A Multistep, Consensus-Based Approach to Organ Allocation in Liver Transplantation: Toward a "blended Principle Model" | Cillo, U; Burra, P; Mazzaferro, V; Belli, L; Pinna, A; Spada, M; Nanni Costa, A; Toniutto, P; Avolio, A; Cescon, M; Romagnoli, R; Santaniello, W; Rossi, M; Corno, V; Caraceni, P; Coco, B; Fraquelli, M; Rendina, M; Angelico, M; Fagiuoli, S; Bruno, R; Costa, A; Ridolfi, L; Romagnoli, R; Pretagostini, R; Amoroso, A; Biancofiore, G; De Gasperi, A; Rocca, G; Feltracco, P; Colli, A; Sacchini, D; Pegoraro, R; Gardini, I; Pipit, P; Maffeo, C; Rossellini, S | Articolo su rivista | |
1-gen-1999 | A pilot study on the safety and effectiveness of immunosuppression without prednisone after liver transplantation | Tisone, G; Angelico, M; Palmieri, G; Pisani, F; Anselmo, A; Baiocchi, L; Negrini, S; Orlando, G; Vennarecci, G; Casciani, Cu | Articolo su rivista | |
1-gen-2004 | A randomized controlled trial of amantadine plus interferon-alpha 2a vs. interferon-alpha 2a alone in naive patients with chronic hepatitis C randomized according to the early virological response to interferon-alpha 2a monotherapy | Angelico, M; Cepparulo, M; Angelico, F; Francioso, S; Barlattani, A; Di Candilo, F; Della Vecchiai, R; Demelia, L; De Sanctis, G; Gentile, S; Grieco, A; Parruti, G; Sabusco, G; Tarquini, L; Tosti, A; Zaru, S | Articolo su rivista | |
1-gen-2009 | A randomized controlled trial of pegylated interferon-alpha2a plus adefovir dipivoxil for hepatitis B e antigen-negative chronic hepatitis B | Piccolo, P; Lenci, I; Demelia, L; Bandiera, F; Piras, M; Antonucci, G; Nosotti, L; Mari, T; De Santis, A; Ponti, M; Sorbello, O; Iacomi, F; Angelico, M | Articolo su rivista | |
1-ago-2013 | A randomized controlled trial of sequential pegylated interferon-α and telbivudine or vice versa for 48 weeks in hepatitis B e antigen-negative chronic hepatitis B | Piccolo, P; Lenci, I; DI PAOLO, D; Demelia, L; Sorbello, O; Nosotti, L; Angelico, M | Articolo su rivista | |
1-gen-2007 | A randomized study on Peg-interferon alfa-2a with or without ribavirin in liver transplant recipients with recurrent hepatitis C | Angelico, M; Petrolati, A; Lionetti, R; Lenci, I; Burra, P; Donato, M; Merli, M; Strazzabosco, M; Tisone, G | Articolo su rivista | |
1-gen-2007 | A randomized study on Peg-interferon alfa-2a with or without ribavirin in liver transplant recipients with recurrent hepatitis C. | Angelico, M; Petrolati, A; Lionetti, R; Lenci, I; Burra, P; Donato, M; Merli, M; Strazzabosco, M; Tisone, G | Articolo su rivista | |
1-feb-2014 | A simple rule to personalize standard dual therapy across all genotypes in naive chronic hepatitis C patients: The TT4 randomized trial | Francioso, S; Almerighi, C; Forte, P; Bandiera, F; Nosotti, L; Lionetti, R; Taliani, G; Piras, M; Ponti, M; Parruti, G; Di Candilo, F; Gentile, S; Piccolo, P; Salso, A; Riccobelli, F; Renzi, S; Longo, M; Montalbano, M; Zaru, S; Biliotti, E; Di Masi, F; Santopaolo, F; Angelico, M | Articolo su rivista | |
26-lug-2019 | A snapshot of virological presentation and outcome of immunosuppression-driven HBV reactivation from real clinical practice: Evidence of a relevant risk of death and evolution from silent to chronic infection | Salpini, R; Battisti, A; Colagrossi, L; Di Carlo, D; Fabeni, L; Piermatteo, L; Cerva, C; Lichtner, M; Mastroianni, C; Marignani, M; Maylin, S; Delaugerre, C; Morisco, F; Coppola, N; Marrone, A; Angelico, M; Sarmati, L; Andreoni, M; Perno, C-; Ceccherini-Silberstein, F; Svicher, V | Articolo su rivista | |
1-nov-2013 | A survey on mortality from non-variceal upper gastrointestinal bleeding: Is the emergency referral system adequate? | Cesaro, P; Kohn, A; Petruziello, L; Angelico, M; Franceschi, F; Gigliozzi, A; Lamazza, A; Tammaro, L; Boschetto, S; Brighi, S; Antoniozzi, A; Baiocchi, L | Articolo su rivista | |
1-gen-2010 | Ab initio calcineurin inhibitor-based monotherapy immunosuppression after liver transplantation reduces the risk for Pneumocystis jirovecii pneumonia. | Orlando, G; Tariciotti, L; Manzia, Tm; Gravante, G; Sorge, R; Manuelli, M; Pisani, F; Di Cocco, P; Scelzo, C; Burke, G; Soker, S; Baiocchi, L; Lerut, J; Angelico, M; Tisone, G | Articolo su rivista | |
1-ott-1982 | Abnormalities in erythrocyte membrane phospholipids in patients with liver cirrhosis | Alvaro, D; Angelico, M; Attili, A; De Santis, A; Piéche, U; Capocaccia, L | Articolo su rivista | |
1-gen-2007 | Activation of the IGF1 system characterizes cholangiocyte survival during progression of primary biliary cirrhosis | Nori, P; Alvaro, D; Floreani, A; Mancino, M; Franchitto, A; Guido, M; Carpino, G; De Santis, A; Angelico, M; Attili, A; Gaudio, E | Articolo su rivista | |
1-gen-2019 | Acute Cholangitis with Atypical Clinical Presentation and Imaging | Masetti, C; Brega, A; Angelico, M | Articolo su rivista |